Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
Where
Beijing
Age
18 years and over
People
28
Run by
Zhijie Wang
See details and how to joinNCT07200947
Phase 2Not yet taking people in China
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
Where
Tianjin
Age
18 years to 75 years
People
165
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07172412
Phase 2Taking people
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
Where
Guangzhou, Zhuhai
Age
18 years and over
People
28
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07181499
Phase 2Taking people
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
Where
Zibo
Age
18 years to 75 years
People
20
Run by
Zibo Municipal Hospital
See details and how to joinNCT07198217
No phaseNot yet taking people in China
A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China
Where
Guangzhou
People
600
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07198620
No phaseNot yet taking people in China
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Where
Shanghai
Age
18 years and over
People
50
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07199010
No phaseTaking people
Study on the Mechanism of Acquired Resistance of Entrectinib
Where
Shanghai
Age
18 years and over
People
38
Run by
Fudan University
See details and how to joinNCT07199959
Phase 2Not yet taking people in China
Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07200154
No phaseTaking people
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Where
Huizhou
Age
18 years to 75 years
People
100
Run by
Guangzhou Medical University
See details and how to joinNCT06304441
Phase 2Taking people
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Where
Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Linyi, Liuzhou, Luoyang, Nanchang, Tianjin, Wuhan, Xi’an, Zhengzhou
Age
18 years to 75 years
People
121
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05956587
Phase 2Taking people
A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC
Where
Hangzhou
Age
18 years and over
People
25
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07193641
No phaseNot yet taking people in China
Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer
Where
Chongqing
Age
18 years and over
People
150
Run by
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07185308
Phase 2Taking people
Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC
Where
Hefei
Age
18 years and over
People
56
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT06838208
Phase 1Taking people
A Study of HLX42 in Advanced/Metastatic Solid Tumors
Where
Guangdong
Age
18 years to 75 years
People
102
Run by
Shanghai Henlius Biotech
See details and how to joinNCT06210815
Phase 2Not yet taking people in China
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC
Where
Beijing
Age
18 years and over
People
62
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07182708
No phaseNot yet taking people in China
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
Where
Tianjin
Age
18 years to 100 years
People
300
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07179445
Phase 2Not yet taking people in China
Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
25
Run by
Xi Junjie
See details and how to joinNCT07064876
Phase 3Not yet taking people in China
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
Where
Shanghai
Age
20 years to 79 years
People
587
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07169903
Phase 1/2Taking people
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Where
Anyang, Baoding, Changde, Dalian, Fuzhou, Guangzhou, Harbin, Hefei, Jinan, Luoyang, Meizhou, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Sichuan, Taiyuan, Tianjin, Xiangyang
Age
18 years to 75 years
People
414
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07169994
Phase 2Enrolling by invitation
Personalized SBRT in Early-Stage Peripheral NSCLC
Where
Tianjin
Age
18 years and over
People
251
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07167459
No phaseTaking people
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
Where
Beijing
Age
18 years to 79 years
People
500
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07166003
No phaseTaking people
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Where
Zhengzhou
Age
60 years and over
People
80
Run by
Jinzhou Medical University
See details and how to joinNCT06512207
No phaseTaking people
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Where
Tianjin
Age
18 years to 80 years
People
84
Run by
Kong Fanming
See details and how to joinNCT06548711
Phase 3Taking people
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Where
Wuhan
Age
18 years to 85 years
People
134
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT07150663
Phase 2Not yet taking people in China
AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment
Where
Guangzhou
Age
18 years to 75 years
People
60
Run by
Akeso
See details and how to joinNCT07158840